Freestone Capital Holdings’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.8M Buy
29,135
+1,771
+6% +$718K 0.4% 45
2025
Q1
$13.6M Buy
27,364
+1,167
+4% +$581K 0.51% 34
2024
Q4
$13.6M Sell
26,197
-348
-1% -$181K 0.47% 38
2024
Q3
$16.4M Buy
26,545
+354
+1% +$219K 0.56% 32
2024
Q2
$14.5M Buy
26,191
+530
+2% +$293K 0.52% 32
2024
Q1
$14.9M Buy
25,661
+509
+2% +$296K 0.56% 32
2023
Q4
$13.4M Sell
25,152
-1,886
-7% -$1M 0.6% 30
2023
Q3
$13.7M Buy
27,038
+5,070
+23% +$2.57M 0.72% 24
2023
Q2
$11.5M Buy
21,968
+810
+4% +$423K 0.46% 41
2023
Q1
$12.2M Buy
21,158
+186
+0.9% +$107K 0.54% 27
2022
Q4
$11.5M Sell
20,972
-494
-2% -$272K 0.53% 29
2022
Q3
$10.9M Sell
21,466
-2,444
-10% -$1.24M 0.49% 27
2022
Q2
$13M Sell
23,910
-3,338
-12% -$1.81M 0.5% 27
2022
Q1
$16.1M Buy
27,248
+5,785
+27% +$3.42M 0.65% 31
2021
Q4
$14.3M Buy
21,463
+928
+5% +$619K 0.61% 35
2021
Q3
$11.7M Sell
20,535
-11
-0.1% -$6.28K 0.59% 37
2021
Q2
$10.4M Buy
20,546
+1,835
+10% +$926K 0.52% 40
2021
Q1
$8.54M Sell
18,711
-433
-2% -$198K 0.46% 53
2020
Q4
$8.92M Sell
19,144
-2,346
-11% -$1.09M 0.52% 40
2020
Q3
$9.49M Sell
21,490
-1,582
-7% -$698K 0.62% 33
2020
Q2
$8.36K Buy
23,072
+4,369
+23% +$1.58K 0.1% 40
2020
Q1
$5.3K Buy
18,703
+4,180
+29% +$1.19K 0.11% 66
2019
Q4
$4.72K Buy
14,523
+2,344
+19% +$761 0.1% 80
2019
Q3
$3.55K Buy
12,179
+4,605
+61% +$1.34K 0.09% 120
2019
Q2
$2.22K Buy
7,574
+361
+5% +$106 0.06% 151
2019
Q1
$1.97M Sell
7,213
-2,868
-28% -$785K 0.12% 158
2018
Q4
$2.26M Buy
10,081
+3,180
+46% +$712K 0.15% 151
2018
Q3
$1.68M Buy
6,901
+1,673
+32% +$408K 0.01% 163
2018
Q2
$1.08M Buy
5,228
+613
+13% +$127K 0.01% 202
2018
Q1
$953K Buy
4,615
+49
+1% +$10.1K 0.06% 216
2017
Q4
$867K Buy
4,566
+172
+4% +$32.7K 0.06% 225
2017
Q3
$831K Buy
4,394
+469
+12% +$88.7K 0.06% 221
2017
Q2
$685K Buy
3,925
+1,304
+50% +$228K 0.05% 228
2017
Q1
$403K Buy
+2,621
New +$403K 0.03% 293
2014
Q1
Sell
-7,062
Closed -$786K 280
2013
Q4
$786K Sell
7,062
-485
-6% -$54K 0.14% 125
2013
Q3
$681K Buy
7,547
+869
+13% +$78.4K 0.12% 166
2013
Q2
$565K Buy
+6,678
New +$565K 0.12% 169